Priority Review Vouchers Could Be Used Frequently Next Year
FDA requests enough pediatric rare disease priority review voucher user fees to fund three redemptions in fiscal year 2016.
FDA requests enough pediatric rare disease priority review voucher user fees to fund three redemptions in fiscal year 2016.